PRF Technologies Ltd
Research PRF Technologies Ltd (PRFX) on Bullrun: market cap USD 1.10M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPRFX
- ExchangeNASDAQ
- CountryIsrael
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 1.10M
- Financial periodFY2025
- RevenueUSD 17.00K
- Net income-USD 5.02M
- Free cash flow-USD 3.96M
- Gross margin-311.8%
Valuation Snapshot
latest market cap is USD 1.10M.
About PRF Technologies Ltd
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd.
Frequently asked questions
What is PRF Technologies Ltd's market cap?
PRF Technologies Ltd's market capitalization is USD 1.10M.
What does PRF Technologies Ltd do?
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery;